Biomarkers Market Worth $93.8 billion | MarketsandMarkets™
/PRNewswire/ -- Biomarkers Market in terms of revenue was estimated to be worth $57.7 billion in 2024 and is poised to reach $93.8 billion by 2029, growing at...
Stay updated with breaking news from Standard Biotools. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Biomarkers Market in terms of revenue was estimated to be worth $57.7 billion in 2024 and is poised to reach $93.8 billion by 2029, growing at...
TD Cowen initiated coverage on shares of Standard BioTools (NASDAQ:LAB – Free Report) in a research report report published on Tuesday morning, Marketbeat.com reports. The firm issued a buy rating and a $3.50 price objective on the stock. Separately, Jefferies Financial Group initiated coverage on shares of Standard BioTools in a research report on Thursday, […]
Standard BioTools Inc. (NASDAQ:LAB – Get Free Report) shares saw unusually-high trading volume on Wednesday . Approximately 2,012,831 shares were traded during trading, a decline of 6% from the previous session’s volume of 2,141,355 shares.The stock last traded at $2.61 and had previously closed at $2.71. Analyst Ratings Changes LAB has been the topic of […]
Shares of Standard BioTools Inc. (NASDAQ:LAB – Get Free Report) traded up 5.8% during mid-day trading on Monday . The stock traded as high as $2.91 and last traded at $2.90. 560,592 shares changed hands during trading, a decline of 73% from the average session volume of 2,039,156 shares. The stock had previously closed at […]
Jefferies Financial Group assumed coverage on shares of Standard BioTools (NASDAQ:LAB – Free Report) in a report released on Thursday, Marketbeat reports. The brokerage issued a buy rating and a $3.25 price objective on the stock. Standard BioTools Stock Up 3.4 % Shares of LAB stock opened at $2.74 on Thursday. Standard BioTools has a […]